Apures Co., Ltd. (XKON:149300)

South Korea flag South Korea · Delayed Price · Currency is KRW
37.00
-1.00 (-2.63%)
At close: Mar 5, 2026
-88.06%
Market Cap 1.64B
Revenue (ttm) 517.33M
Net Income (ttm) -3.73B
Shares Out 45.49M
EPS (ttm) -138.55
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 47,312
Average Volume 57,510
Open 38.00
Previous Close 38.00
Day's Range 33.00 - 38.00
52-Week Range 17.00 - 367.00
Beta -0.85
RSI 42.96
Earnings Date n/a

About Apures

Apures Co., Ltd. engages in the development and commercialization of solutions for the bio and medical industries in South Korea. It is involved in the development of MICROPIG, which are research and laboratory mini pig species to provide solutions through standardization of biomaterials for medical experiments and development of regenerative medicine treatments, including cell therapy and heterogeneous organs. The company provides Porcine Primary Cell for in vitro test. It also manufactures and supplies Bio Membrane under the FCM brand, which ... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2001
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 149300
Full Company Profile

Financial Performance

In 2018, Apures's revenue was 528.64 million, an increase of 28.45% compared to the previous year's 411.56 million. Losses were -4.68 billion, -16.82% less than in 2017.

Financial Statements

News

There is no news available yet.